Next Article in Journal / Special Issue
Antioxidants from the Brown Alga Dictyopteris undulata
Previous Article in Journal
Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative Bacteria
Previous Article in Special Issue
Identification of Insecticidal Constituents from the Essential Oil from the Aerial Parts Stachys riederi var. japonica
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessReview
Molecules 2018, 23(5), 1213; https://doi.org/10.3390/molecules23051213

Echinacoside, an Inestimable Natural Product in Treatment of Neurological and other Disorders

1
Department of Pharmaceutical Analysis, School of Pharmacy, Ningxia Medical University, 1160 Shenli Street, Yinchuan 750004, China
2
Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, 1160 Shenli Street, Yinchuan 750004, China
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editors: Nancy D. Turner and Isabel C. F. R. Ferreira
Received: 1 May 2018 / Revised: 12 May 2018 / Accepted: 15 May 2018 / Published: 18 May 2018
(This article belongs to the Collection Bioactive Compounds)
Full-Text   |   PDF [1164 KB, uploaded 18 May 2018]   |  

Abstract

Echinacoside (ECH), a natural phenylethanoid glycoside, was first isolated from Echinacea angustifolia DC. (Compositae) sixty years ago. It was found to possess numerous pharmacologically beneficial activities for human health, especially the neuroprotective and cardiovascular effects. Although ECH showed promising potential for treatment of Parkinson’s and Alzheimer’s diseases, some important issues arose. These included the identification of active metabolites as having poor bioavailability in prototype form, the definite molecular signal pathways or targets of ECH with the above effects, and limited reliable clinical trials. Thus, it remains unresolved as to whether scientific research can reasonably make use of this natural compound. A systematic summary and knowledge of future prospects are necessary to facilitate further studies for this natural product. The present review generalizes and analyzes the current knowledge on ECH, including its broad distribution, different preparation technologies, poor pharmacokinetics and kinds of therapeutic uses, and the future perspectives of its potential application. View Full-Text
Keywords: echinacoside; preparation; pharmacokinetics; Parkinson’s disease; Alzheimer’s disease echinacoside; preparation; pharmacokinetics; Parkinson’s disease; Alzheimer’s disease
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Liu, J.; Yang, L.; Dong, Y.; Zhang, B.; Ma, X. Echinacoside, an Inestimable Natural Product in Treatment of Neurological and other Disorders. Molecules 2018, 23, 1213.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top